Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Hillcrest Medical Center located at 1120 S Utica Ave, Tulsa, OK, 74104 & includes data from NPIs 1679652192, 1629057229
Dexur analyzed Q3 2019 (July to September 2019) Medicare claims data to benchmark length of stay (LOS) outcomes for Hillcrest Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,844 | 1,709 | ||||||||||
| Surgical | 552 | 526 | ||||||||||
| Non Surgical | 1,292 | 1,183 | ||||||||||
| Cardiovascular | 570 | 533 | ||||||||||
| General Medicine | 248 | 218 | ||||||||||
| Orthopedics | 177 | 172 | ||||||||||
| Neurology | 168 | 156 | ||||||||||
| Pulmonology | 153 | 143 | ||||||||||
| General Surgery | 137 | 125 | ||||||||||
| Urology | 131 | 124 | ||||||||||
| Gastroenterology & Endocrinology | 129 | 116 | ||||||||||
| Oncology & Hematology | 54 | 49 | ||||||||||
| Spine | 26 | 26 | ||||||||||
| Psychiatry & Mental Disorders | 14 | 12 | ||||||||||
| Obstetrics & Gynecology | 14 | 13 | ||||||||||
| Dermatology | 11 | NA | ||||||||||
| Colorectal | 11 | 11 |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Coronary Bypass | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Hypertension | ||||||||||||
| DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| Carotid Artery Stent Procedures | ||||||||||||
| Aortic And Heart Assist Procedures | ||||||||||||
| Atherosclerosis |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| Complications Of Treatment | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| Seizures | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| Respiratory Infections And Inflammations |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other O.R. Procedures For Injuries | ||||||||||||
| Major Chest Procedures |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Ureter Procedures |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| Respiratory Neoplasms |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures |